Diabetes, obesity & metabolism · 2026
Impact of Simulated Risk Factor Management on Cardiovascular Disease and Costs in Type 2 Diabetes Using the ABC Model.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lim Lee-Ling, Lau Eric S H, Lui Juliana N M, Ji Linong, Unnikrishnan A G, Sirinvaravong Sirinart, Chan Siew-Pheng, Lim Soo, Luk Andrea O Y, Chan Juliana C N
Аннотация
AIMS: We evaluated the impact of scenario-based multifactorial control on the 3-year incidence of fatal/non-fatal cardiovascular disease (CVD) and associated healthcare costs in Asian patients with type 2 diabetes (T2D).
MATERIALS AND METHODS: We applied the validated 'ABC' model to simulate the 3-year impact of attaining multiple treatment targets (HbA1c < 7%, blood pressure [BP] < 130/80 mmHg, risk-stratified LDL-C target [ABC], smoking cessation and weight reduction) on the incidence of fatal/non-fatal CVD (ischaemic heart disease and stroke) in patients with T2D enrolled from 11 Asian countries/jurisdictions in the Joint Asia Diabetes Evaluation (JADE) Register. We estimated the costs of these simulated CVD events and potential cost savings with multifactorial intervention.
RESULTS: Amongst 103 958 patients with T2D (53.4% men, 12.0% current smokers, mean [SD] age 57.6 [11.8], HbA1c 7.96 [1.87], systolic BP 132.0 [17.4] mmHg, LDL-C 2.6 [0.95] mmol/L, BMI 26.2 [4.5] kg/m2), 17 151 (16.5%) had prior CVD and 86 807 (83.5%) had no CVD at baseline. In the CVD group, 1.5% achieved all three ABC targets and 5.1% in the nonCVD group at baseline. In the CVD group, the estimated incidence rate for CVD was 61.60 per 1000-person-years (PY), and 11.65 per 1000-PY in the non-CVD group. Simulated achievement of all three ABC targets reduced the incidence rates by 35.1%-40.01% per 1000-PY in the CVD group and by 30.2%-8.13% per 1000-PY in the non-CVD group. In China, these scenario-based simulations might avert 1 177 682 CVD events per year with a potential saving of US$ 11 292 823 476.
CONCLUSIONS: Multifactorial management of cardiometabolic risk factors may have a substantial impact on CVD prevention, with cost savings in patients with T2D.
MATERIALS AND METHODS: We applied the validated 'ABC' model to simulate the 3-year impact of attaining multiple treatment targets (HbA1c < 7%, blood pressure [BP] < 130/80 mmHg, risk-stratified LDL-C target [ABC], smoking cessation and weight reduction) on the incidence of fatal/non-fatal CVD (ischaemic heart disease and stroke) in patients with T2D enrolled from 11 Asian countries/jurisdictions in the Joint Asia Diabetes Evaluation (JADE) Register. We estimated the costs of these simulated CVD events and potential cost savings with multifactorial intervention.
RESULTS: Amongst 103 958 patients with T2D (53.4% men, 12.0% current smokers, mean [SD] age 57.6 [11.8], HbA1c 7.96 [1.87], systolic BP 132.0 [17.4] mmHg, LDL-C 2.6 [0.95] mmol/L, BMI 26.2 [4.5] kg/m2), 17 151 (16.5%) had prior CVD and 86 807 (83.5%) had no CVD at baseline. In the CVD group, 1.5% achieved all three ABC targets and 5.1% in the nonCVD group at baseline. In the CVD group, the estimated incidence rate for CVD was 61.60 per 1000-person-years (PY), and 11.65 per 1000-PY in the non-CVD group. Simulated achievement of all three ABC targets reduced the incidence rates by 35.1%-40.01% per 1000-PY in the CVD group and by 30.2%-8.13% per 1000-PY in the non-CVD group. In China, these scenario-based simulations might avert 1 177 682 CVD events per year with a potential saving of US$ 11 292 823 476.
CONCLUSIONS: Multifactorial management of cardiometabolic risk factors may have a substantial impact on CVD prevention, with cost savings in patients with T2D.